375 related articles for article (PubMed ID: 19903292)
1. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
2. An alternative mini buffy coat preparation method for adult patients with extracorporeal photopheresis contraindications.
Grabmer C; Schlager S; Mayer G; Streif D; Lener T; Schallmoser K; Rohde E
J Clin Apher; 2017 Feb; 32(1):12-15. PubMed ID: 26939709
[TBL] [Abstract][Full Text] [Related]
3. An automated mini buffy coat preparation method for use in mini extracorporeal photopheresis treatment of graft-vs-host-disease in a low body weight pediatric patient.
Matic T; Bojanic I; Mazic S; Golubic Cepulic B; Bilic E
J Clin Apher; 2019 Aug; 34(4):468-473. PubMed ID: 30829417
[TBL] [Abstract][Full Text] [Related]
4. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure.
Schneiderman J; Jacobsohn DA; Collins J; Thormann K; Kletzel M
J Clin Apher; 2010; 25(2):63-9. PubMed ID: 20301140
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
6. A simplified extracorporeal photopheresis procedure based on single high-dose ultraviolet A light irradiation shows similar in vitro efficacy.
Buchele V; Hackstein H
Transfusion; 2021 Mar; 61(3):883-893. PubMed ID: 33300629
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis: what is it and when should it be used?
Scarisbrick J
Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
[TBL] [Abstract][Full Text] [Related]
8. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
Liu C; Shah K; Dynis M; Eby CS; Grossman BJ
Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
[TBL] [Abstract][Full Text] [Related]
9. An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
Budde H; Papert S; Reichardt HM; Jarry H; Riggert J; Legler TJ
Vox Sang; 2018 Nov; 113(8):803-810. PubMed ID: 30353554
[TBL] [Abstract][Full Text] [Related]
10. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
[TBL] [Abstract][Full Text] [Related]
11. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
[TBL] [Abstract][Full Text] [Related]
12. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance.
Kusztal M; Kłak R; Krajewska M; Boratyńska M; Patrzałek D; Klinger M
Transplant Proc; 2011 Oct; 43(8):2941-2. PubMed ID: 21996195
[TBL] [Abstract][Full Text] [Related]
13. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
Spisek R; Gasova Z; Bartunkova J
Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
[TBL] [Abstract][Full Text] [Related]
14. Mini photopheresis for refractory chronic graft-versus-host disease in children and adolescents.
Verdú-Amorós J; Woessmann W; Maecker-Kolhoff B; Schulz A; Strauss G; Bein G; Hackstein H
Transfusion; 2018 Nov; 58(11):2495-2500. PubMed ID: 30291766
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photopheresis: clinical use so far.
Sanford KW; Balogun RA
J Clin Apher; 2012; 27(3):126-31. PubMed ID: 22467383
[TBL] [Abstract][Full Text] [Related]
17. Apheresis buffy coat collection without photoactivation has no effect on apoptosis, cell proliferation, and total viability of mononuclear cells collected using photopheresis systems.
Szczepiorkowski ZM; Burnett CA; Dumont LJ; Abhyankar SH
Transfusion; 2018 Apr; 58(4):943-950. PubMed ID: 29451308
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures.
Perotti C; Torretta L; Viarengo G; Roveda L; Bernuzzi S; Carbone S; Del Fante C; La Torre R; Locatelli F; Bonetti F; Gabba P; Bellosta M; Salvaneschi L
Haematologica; 1999 Mar; 84(3):237-41. PubMed ID: 10189389
[TBL] [Abstract][Full Text] [Related]
19. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
Darvay A; Salooja N; Russell-Jones R
J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
[TBL] [Abstract][Full Text] [Related]
20. Photopheresis in pediatric patients with low-body weight using the UVAR XTS system.
Hillen U; Meyer S; Schadendorf D; Kremens B
J Dtsch Dermatol Ges; 2010 Jan; 8(1):32-7. PubMed ID: 19751224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
